HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Modeling diabetes disease progression and salsalate intervention in Goto-Kakizaki rats.

Abstract
Type 2 diabetes mellitus (T2DM) arises owing to insulin resistance and β-cell dysfunction. Chronic inflammation is widely identified as a cause of T2DM. The Goto-Kakizaki (GK) rat is a spontaneous rodent model for T2DM with chronic inflammation. The purpose of this study was to characterize diabetes progression in GK rats and evaluate the potential role of the anti-inflammatory agent salsalate. The GK rats were divided into control groups (n = 6) and salsalate treatment groups (n = 6), which were fed a salsalate-containing diet from 5 to 21 weeks of age. Blood glucose and salicylate concentrations were measured once a week. Glucose concentrations showed a biphasic increase in which the first phase started at approximately 5 weeks, resulting in an increase by 15 to 25 mg/dl and a second phase at 14 to 15 weeks with an upsurge of more than 100 mg/dl. A mechanism-based model was proposed to describe the natural diabetes progression and salsalate pharmacodynamics by using a population method in S-ADAPT. Two transduction cascades were applied to mimic the two T2DM components: insulin resistance and β-cell dysfunction. Salsalate suppressed both disease factors by a fraction of 0.622 on insulin resistance and 0.134 on β-cell dysfunction. The substantial alleviation of diabetes by salsalate supports the hypothesis that chronic inflammation is a pathogenic factor of diabetes in GK rats. In addition, body weight and food intake were measured and further modeled by a mechanism-based growth model. Modeling results suggest that salsalate reduces weight gain by enhancing metabolic rate and energy expenditure in both GK and Wister-Kyoto rats.
AuthorsYanguang Cao, Debra C Dubois, Hao Sun, Richard R Almon, William J Jusko
JournalThe Journal of pharmacology and experimental therapeutics (J Pharmacol Exp Ther) Vol. 339 Issue 3 Pg. 896-904 (Dec 2011) ISSN: 1521-0103 [Electronic] United States
PMID21903749 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Blood Glucose
  • Salicylates
  • salicylsalicylic acid
  • Sodium Salicylate
Topics
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal (blood, pharmacokinetics, therapeutic use)
  • Blood Glucose (analysis)
  • Body Weight
  • Diabetes Mellitus, Type 2 (drug therapy, metabolism, pathology, physiopathology)
  • Disease Models, Animal
  • Disease Progression
  • Male
  • Models, Biological
  • Random Allocation
  • Rats
  • Rats, Inbred WKY
  • Salicylates (blood, pharmacokinetics, therapeutic use)
  • Sodium Salicylate (blood, pharmacokinetics)
  • Software

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: